0000950170-24-001386.txt : 20240103
0000950170-24-001386.hdr.sgml : 20240103
20240103201257
ACCESSION NUMBER: 0000950170-24-001386
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240103
DATE AS OF CHANGE: 20240103
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Dyne Therapeutics, Inc.
CENTRAL INDEX KEY: 0001818794
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 364883909
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-39509
FILM NUMBER: 24509363
BUSINESS ADDRESS:
STREET 1: 1560 TRAPELO ROAD
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781) 786-8230
MAIL ADDRESS:
STREET 1: 1560 TRAPELO ROAD
CITY: WALTHAM
STATE: MA
ZIP: 02451
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Beskrovnaya Oxana
CENTRAL INDEX KEY: 0001824542
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: C/O DYNE THERAPEUTICS, INC.
STREET 2: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
144
1
primary_doc.xml
144
0001824542
XXXXXXXX
LIVE
0001818794
Dyne Therapeutics, Inc.
001-39509
1560 Trapelo Road
Waltham
MA
02451
(781)-786-8230
Oxana Beskrovnaya
Officer
Common Stock
Stifel Financial Corporation
3 Bryant Park, 4th Floor
1095 Avenue of the Americas
New York
NY
10036
45326
860378
61375598
01/03/2024
NASDAQ
Common Stock
01/03/2024
Stock option exercise
Issuer
N
45326
01/03/2024
Cash
N
Oxana Beskrovnaya
1560 Trapelo Road
Waltham
MA
02451
Common Stock
12/11/2023
1467
15726
The sales reported in this Form 144 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 30, 2023. Securities sold on December 11, 2023 represent shares sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on December 10, 2021 and December 9, 2022.
01/03/2024
06/30/2023
/s/ Richard Scalzo, Attorney-in-Fact